Cargando…
A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study
We aimed to explore whether changes in circulating levels of miRNAs according to type 2 diabetes mellitus (T2DM) or prediabetes status could be used as biomarkers to evaluate the risk of developing the disease. The study included 462 patients without T2DM at baseline from the CORDIOPREV trial. After...
Autores principales: | Jiménez-Lucena, Rosa, Camargo, Antonio, Alcalá-Diaz, Juan Francisco, Romero-Baldonado, Cristina, Luque, Raúl Miguel, van Ommen, Ben, Delgado-Lista, Javier, Ordovás, Jose María, Pérez-Martínez, Pablo, Rangel-Zúñiga, Oriol Alberto, López-Miranda, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312530/ https://www.ncbi.nlm.nih.gov/pubmed/30598522 http://dx.doi.org/10.1038/s12276-018-0194-y |
Ejemplares similares
-
Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study
por: Jiménez-Lucena, Rosa, et al.
Publicado: (2018) -
A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
por: Rangel-Zuñiga, Oriol Alberto, et al.
Publicado: (2020) -
An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study
por: Vals-Delgado, Cristina, et al.
Publicado: (2021) -
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
por: Mora-Ortiz, Marina, et al.
Publicado: (2022) -
Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study
por: Leon-Acuña, A., et al.
Publicado: (2016)